| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Vlad Coric | Chief Executive Officer, Director | $274M | Oct 3, 2022 | ||
| Declan Doogan | Director | $222M | Dec 31, 2021 | ||
| John Tilton | Chief Commercial Officer | $240K | Oct 3, 2022 | ||
| George Clark | VP, Chief Accounting Officer | Oct 3, 2022 | |||
| Kimberly Gentile | SVP, Clinical Operations | Oct 3, 2022 | |||
| Elyse Stock | Chief Medical Officer | Oct 3, 2022 | |||
| Matthew Buten | Chief Financial Officer | Oct 3, 2022 | |||
| Julia P. Gregory | Director | Oct 3, 2022 | |||
| Gregory Bailey | Director | Oct 3, 2022 | |||
| Irina Antonijevic | Director | Oct 3, 2022 | |||
| Charles Conway | Chief Scientific Officer | Oct 3, 2022 | |||
| James Engelhart | Strategic Advisor | Oct 3, 2022 | |||
| William Jones | CCO-Migraine & Common Disease | Oct 3, 2022 | |||
| John W. Childs | Director | Oct 3, 2022 | |||
| Robert J. Hugin | Director | Oct 3, 2022 | |||
| Michael Thomas Heffernan | Director | Oct 3, 2022 | |||
| Kishan Mehta | Director | Oct 3, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|